Clinical Trial Update: Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of HAV in patients requiring vascular access for dialysis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Renal Failure
• Vascular Access For Hemodialysis

Drugs mentioned

• HAV

Snippet

Sponsor: Humacyte, Inc. | Conditions: Renal Failure, End Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-02-23